Showing results (171-180 of 224) with videos related to
Sort By:
Pageof 23
International Journal of Ophthalmology|February 3, 2017
Six-year outcomes in neovascular age-related macular degeneration with ranibizumabJulie Jacob, Heidi Brié, Anita Leys, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|September 17, 2013
Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patientsIvo Abraham, Yoleen Van Camp, Lorenzo Villa, et al.JAMA Dermatology|November 27, 2018
Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable MelanomaAbdulaali R Almutairi, Nimer S Alkhatib, Mok Oh, et al.International Journal of Spine Surgery|February 18, 2022
A Differential Clinical Benefit Examination of Full Lumbar Endoscopy vs Interspinous Process Spacers in the Treatment of Spinal Stenosis: An Effect Size Meta-Analysis of Clinical OutcomesKai-Uwe Lewandrowski, Ivo Abraham, Jorge Felipe Ramírez León, et al.Annals of Hematology|February 15, 2011
Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromesMichel Delforge, Dominik Selleslag, Agnès Triffet, et al.Expert Opinion on Drug Safety|January 14, 2020
Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysisNasser Alkhushaym, Abdulaali R Almutairi, Abdulhamid Althagafi, et al.Journal of Medical Economics|October 4, 2018
Economic evaluation of a pharmacogenomic multi-gene panel test to optimize anti-hypertension therapy: simulation studyEli F Kelley, Eric M Snyder, Nimer S Alkhatib, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 26, 2020
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart FailureNimer Alkhatib, Nancy K Sweitzer, Christopher S Lee, et al.Leukemia Research|August 31, 2019
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilizationLeslie A Andritsos, Ying Huang, Ivo Abraham, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 13, 2019
Variability in total serum IgE over 1 year in severe asthmaticsRenaud Louis, Charles Pilette, Olivier Michel, et al.Pageof 23